Home
User Profile
  • From first to last
  • 2005-2010 B. S. Biology in the University of Navarra (Spain)
  • 2005-2010 B. S. Biochemistry in the University of Navarra (Spain)
  • 2010-2011 M. S. Biomedical Research in the University of Navarra (Spain)
  • 2011-2016 PhD in Microbiology in the University of Navarra (Spain)
  • 2014-2014 Visiting researcher in the Center for Biofilm Engineering (CBE) in Montana State University (MSU) (USA)
  • 2017-Present Research Fellow in Wellman Center for Photomedicine in Mass General Hospital (USA)
  • 1. Sánchez-Gómez S, Ferrer-Espada R, Stewart PS, Pitts B, Lohner K, Martínez de Tejada G (2015) Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. BMC Microbiol 15:137. doi: 10.1186/s12866-015-0473-x
  • 2. Heinbockel L, Marwitz S, Barcena Varela S, Ferrer-Espada R, Reiling N, Goldmann T, Gutsmann T, Mier W, Schürholz T, Drömann D, Brandenburg K, Martínez de Tejada G (2015) Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis. PLoS ONE 10:e0133291. doi: 10.1371/journal.pone.0133291
  • 3. Martínez de Tejada G, Heinbockel L, Ferrer-Espada R, Heine H, Alexander C, Barcena Varela S, Goldmann T, Correa W, Wiesmüller K-H, Gisch N, Sánchez-Gómez S, Fukuoka S, Schürholz T, Gutsmann T, Brandenburg K (2015) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides. Sci Rep 5:14292. doi: 10.1038/srep14292
  • 4. López-Goñi I, Martínez-Viñas MJ, Antón J, Cid VJ, Martín González A, Brown-Jaque M, García-Lobo JM, Sánchez M, Vilchez JI, Robledo-Mahón T, Seder-Colomina M, Tapia-Paniagua ST, de Rojas AH, Mira A, Gallego-Parrilla JJ, López Díaz TM, Maicas I Prieto S, Villalobo E, Quindós G, Balboa S, Romalde JL, Aguilar-Pérez C, Tomás A, Linares M, Zaragoza O, Gil-Serna J, Ferrer-Espada R, Camacho AI, Vinué L, García-Lara J (2016) Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative. J Microbiol Biol Educ 17:492–494. doi: 10.1128/jmbe.v17i3.1200
  • 5. Wang Y, Ferrer-Espada R, Gu Y, Dai T (2017) Antimicrobial Blue Light: An Alternative Therapeutic for Multidrug-Resistant Gonococcal Infections? Open Access Journal of Photoenergy 1:1–3. doi: 10.15406/oajp.2017.01.00009
  • Book chapters
  • 1. Shahrour H, Ferrer-Espada R, Dandache I, Barcena-Varela S, Sánchez-Gómez S, Chokr A and Martínez-de-Tejada G (2018, In press) AMPs as anti-biofilm agents for human therapy and prophylaxis. In: Antimicrobial Peptides: Basics for Clinical Application. Springer nature.
  • Conference proceedings
  • 1. Ferrer-Espada R, Fang Y, Dai T (2018) Antimicrobial blue light inactivation of biofilms formed by clinical isolates of multidrug-resistant microorganisms. In: Dai T (ed) Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases. SPIE, pp 22–9
  • 1. Antimicrobial blue light in biofilms
  • 2. Antimicrobial blue light in urinary tract infections
  • 3. Antimicrobial blue light mechanism of action